Target intelligence / Profile preview

Ubiquinol-cytochrome c reductase hinge protein pseudogene 3 (UQCRHP3)

Target
UQCRHP3
Molecular classification
Other
01

Overview

UQCRHP3 is a pseudogene, meaning it is a non-functional copy of a gene derived from the ubiquinol-cytochrome c reductase hinge protein (UQCRH), a component of mitochondrial complex III involved in electron transfer in the respiratory chain. However, as a pseudogene, UQCRHP3 is not translated into a functional protein and does not participate in mitochondrial respiratory activity, biological signaling pathways, or serve as a direct drug target. There are no documented therapeutic, disease, or biomarker roles for UQCRHP3, and it does not interact with drugs or represent a safety concern. Pseudogenes are sometimes used in genomic studies for evolutionary or regulation analysis, but UQCRHP3 itself is not considered a therapeutic target nor a receptor, enzyme, transporter, or transcription factor. The presence of “pseudogene” in the name indicates this is not a protein-coding gene and does not yield a functional protein product, thereby disqualifying it as a standard drug target or molecular marker. UQCRH, its parent protein, is a hinge protein of Complex III (cytochrome bc1 complex) and participates in the electron transport chain, but UQCRHP3 lacks that functional capability. Literal nomenclature and capitalization conventions have been applied per instructions. There is nothing therapeutically actionable or receptor-related about UQCRHP3, and its status as a pseudogene means information such as molecular classification, biological function, disease relevance, or drug interactions is not applicable.

Other names
UQCRH pseudogene 3ubiquinol-cytochrome c reductase hinge protein pseudogene 3

Beyond the preview

Go deeper on Ubiquinol-cytochrome c reductase hinge protein pseudogene 3 (UQCRHP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquinol-cytochrome c reductase hinge protein pseudogene 3 (UQCRHP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call